WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr | ₹1,012 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹60 Cr |
Mar2023 | ₹1,072 Cr |
Mar2022 | ₹934 Cr |
Mar2021 | ₹889 Cr |
Mar2020 | ₹1,012 Cr |
How is Contingent Liabilities of WANBURY Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹60 Cr | -94.40 | |
Mar2023 | ₹1,072 Cr | 14.78 | |
Mar2022 | ₹934 Cr | 5.01 | |
Mar2021 | ₹889 Cr | -12.14 | |
Mar2020 | ₹1,012 Cr | - |
Compare Contingent Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹872.7 Cr | 1.5% | -8% | -7.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | -2% | 2% | -16.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -5% | -6.6% | 5.9% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | -2.4% | -5.4% | -8.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | -0.4% | 0.5% | 5.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -5.8% | -4.4% | -8.4% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 1.5% |
-8% |
-7.1% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses